Zydus Cadila gets DCGI nod to initiate Phase-3 clinical trials for COVID-19 vaccine
Vaccine ZyCoV-D was found to be safe, well-tolerated and immunogenic in phase I and II clinical trials
Full Article
Zydus Cadila gets DCGI nod to initiate Phase-3 clinical trials for COVID-19 vaccine
Hindu
0 shares
1 views
You might like
Related news coverage
Dr. Reddy’s seeks DCGI nod for Sputnik-V phase-3 trials
Hindu
Pharma major Dr. Reddy’s Laboratories on Monday said safety data pertaining to phase-2 clinical trial of Russia’s Sputnik-V..
-
Shashi Tharoor critcises Centre for giving nod to Bharat Biotech vaccine without phase 3 trials
Mid-Day
-
Zydus Cadila gets nod for phase 3 trials of its COVID-19 vaccine candidate
Mid-Day
-
Zydus Cadila gets DCGI nod to initiate Phase-3 clinical trials for Covid-19 vaccine
IndiaTimes
-
Expert panel recommends Bharat Biotech's Covaxin for emergency use
Mid-Day